Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fortis HealthcareNSE:FORTIS -1.36%86 EV-to-EBITDA is 33.07 as of Sep. 04, 2026, which is 71% above its 10-year median of 19.39. GuruFocus rates NSE:FORTIS with a GF Score™ of 86/100 and a GF Value™ of ₹870.12 (Fairly Valued). The stock has 1 warning sign investors should review. Among 515 Healthcare Providers & Services companies, Fortis Healthcare ranks worse than 87.77% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Fortis Healthcare's enterprise value is ₹718,881 Mil.
Fortis Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₹21,736 Mil. Therefore, Fortis Healthcare's EV-to-EBITDA for today is 33.07.
The historical rank and industry rank for Fortis Healthcare's EV-to-EBITDA or its related term are showing as below:
NSE:FORTIS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -25.34 Med: 19.39 Max: 43.46
Current: 33.08
During the past 13 years, the highest EV-to-EBITDA of Fortis Healthcare was 43.46. The lowest was -25.34. And the median was 19.39.
NSE:FORTIS's EV-to-EBITDA is ranked worse than 87.77% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.46
vs NSE:FORTIS: 33.08
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fortis Healthcare's PE Ratio (TTM) for today is calculated as:
Fortis Healthcare's share price for today is ₹905.00.
Fortis Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹13.880.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Fortis Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:FORTIS vs HCA, THC, EHC: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Fortis Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortis Healthcare EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fortis Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Fortis Healthcare's EV-to-EBITDA falls into.
Fortis Healthcare's current Enterprise Value is ₹718,881 Mil.
Fortis Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹21,736 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fortis Healthcare (NSE:FORTIS) has a EV-to-EBITDA of 33.07 as of Sep. 04, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Fortis Healthcare. This is 71% above median its historical median of 19.39. According to the industry distribution chart, Fortis Healthcare ranks #452 out of 515 companies in the Healthcare Providers & Services industry, placing it in the top 87.8%.
Is Fortis Healthcare's EV-to-EBITDA too high?
Fortis Healthcare's current EV-to-EBITDA of 33.07 is 71% above median its 10-year median of 19.39. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.46. Fortis Healthcare's value of 33.07 is 216.2% above this industry median. Based on the distribution chart, Fortis Healthcare ranks #452 out of 515 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Fortis Healthcare has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fortis Healthcare's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fortis Healthcare ranks #452 out of 515 companies for EV-to-EBITDA. This places Fortis Healthcare in the lower half of its industry. The industry median EV-to-EBITDA is 10.46. Fortis Healthcare's value of 33.07 is 216.2% above this benchmark. While the company's 10-year median is 19.39 vs. the industry median of 10.46, Fortis Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.46, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fortis Healthcare's current EV-to-EBITDA of 33.07 is 216.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Fortis Healthcare. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fortis Healthcare's current EV-to-EBITDA is 33.07, which is 71% above median its own 10-year median of 19.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fortis Healthcare (NSE:FORTIS) is currently considered Fairly Valued. The stock's GF Value™ is ₹870.12, compared to a current price of ₹905.00 — trading 4% above its estimated fair value. The current EV-to-EBITDA is 33.07, which is 71% above median its 10-year median of 19.39 and 216.2% above the Healthcare Providers & Services industry median of 10.46. Fortis Healthcare's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Fortis Healthcare (NSE:FORTIS), the current EV-to-EBITDA is 33.07 as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fortis Healthcare (NSE:FORTIS) Overvalued in 2026?
Based on GuruFocus' analysis, Fortis Healthcare stock appears to be overvalued.
The current stock price of ₹905.00 is trading 4% above its estimated GF Value™ of ₹870.12.
GuruFocus considers Fortis Healthcare to be Fairly Valued.
Key valuation signals for NSE:FORTIS:
EV-to-EBITDA: 33.07 (71% above median its 10-year median of 19.39)
GF Value™: ₹870.12 vs. price of ₹905.00 (4% above fair value)
Industry Position: 216.2% above the Healthcare Providers & Services median (#452 of 515)
No single metric tells the full story. See the NSE:FORTIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fortis Healthcare Ltd provides integrated healthcare delivery services in India. The company manages healthcare centers including hospitals, diagnostics, and day care specialty facilities. The company's key specialty in its hospital business is cardiac sciences. It is predominantly engaged in the business of healthcare services which is the only reportable segment. The company's key hospitals include Fortis Escorts Heart Institute in Dehli, Fortis Mulund in Mumbai, and Fortis Hospital in Bengaluru. The majority of the company's revenue is derived from India.
86GF Score
Get the complete analysis for NSE:FORTIS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:FORTIS has been successfully added to your 
